Literature DB >> 22022331

Acute Cerebral Infarction Following Intravenous Glycoprotein IIb/IIIa Inhibitor for Acute Myocardial Infarction.

Woong Gil Choi1, Se Won Oh, Young Joong Kim, Jong Gu Lim, Yoon Sik Jo.   

Abstract

Stroke is a rare but serious complication of acute myocardial infarction (AMI). Currently, glycoprotein (GP) IIb/IIIa inhibitor is used in clinical practice for acute coronary syndromes and percutaneous coronary interventions (PCIs). The incidence of stroke in patients receiving GP IIb/IIIa inhibitor during PCIs is very low. We report the case of a 47-year-old man who presented with AMI and suffered an acute cerebral infarction after infusion of a GP IIb/IIIa inhibitor following primary PCI.

Entities:  

Keywords:  Acute stroke; Myocardial infarction; Platelet glycoprotein GP IIb-IIIa complex

Year:  2011        PMID： 22022331      PMCID： PMC3193047          DOI： 10.4070/kcj.2011.41.9.546

Source DB:  PubMed          Journal:  Korean Circ J        ISSN： 1738-5520            Impact factor:   3.243


  8 in total

1.  Ischemic stroke. Impact of a recent myocardial infarction.

Authors:  T Mooe; B O Olofsson; B Stegmayr; P Eriksson
Journal:  Stroke       Date:  1999-05       Impact factor: 7.914

2.  An ischemic stroke during intravenous recombinant tissue plasminogen activator infusion for evolving myocardial infarction.

Authors:  G Y Chang
Journal:  Eur J Neurol       Date:  2001-05       Impact factor: 6.089

3.  Risk of stroke associated with abciximab among patients undergoing percutaneous coronary intervention.

Authors:  K M Akkerhuis; J W Deckers; A M Lincoff; J E Tcheng; E Boersma; K Anderson; C Balog; R M Califf; E J Topol; M L Simoons
Journal:  JAMA       Date:  2001-07-04       Impact factor: 56.272

4.  Effect of intravenous tirofiban and aspirin in reducing short-term and long-term neurologic deficit in patients with ischemic stroke: a double-blind randomized trial.

Authors:  G Torgano; B Zecca; V Monzani; A Maestroni; P Rossi; M Cazzaniga; D Manganaro; C Boiti; E Zilioli; G Borutti; F Falaschi; C Mandelli
Journal:  Cerebrovasc Dis       Date:  2010-01-15       Impact factor: 2.762

Review 5.  Coronary artery disease, myocardial infarction, and brain embolism.

Authors:  D C Hess; I A D'Cruz; R J Adams; F T Nichols
Journal:  Neurol Clin       Date:  1993-05       Impact factor: 3.806

Review 6.  Novel antiplatelet therapies for treatment of patients with ischemic heart disease: inhibitors of the platelet glycoprotein IIb/IIIa integrin receptor.

Authors:  W H Frishman; B Burns; B Atac; N Alturk; B Altajar; K Lerrick
Journal:  Am Heart J       Date:  1995-10       Impact factor: 4.749

7.  Cerebrovascular accident complicating acute myocardial infarction: incidence, clinical significance and short- and long-term mortality rates. The SPRINT Study Group.

Authors:  S Behar; D Tanne; E Abinader; J Agmon; J Barzilai; Y Friedman; E Kaplinsky; N Kauli; Y Kishon; A Palant
Journal:  Am J Med       Date:  1991-07       Impact factor: 4.965

8.  Myocardial infarction and stroke.

Authors:  M S Komrad; C E Coffey; K S Coffey; R McKinnis; E W Massey; R M Califf
Journal:  Neurology       Date:  1984-11       Impact factor: 9.910
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.